Brief: Creative Medical Technology Holdings Announces World Health Organization Approval Of “Olastrocel”
02/12/2025 14:16
Dec 2 (Reuters) - Creative Medical Technology Holdings Inc CELZ.O: CREATIVE MEDICAL TECHNOLOGY HOLDINGS ANNOUNCES WORLD HEALTH ORGANIZATION APPROVAL OF “OLASTROCEL” AS INN FOR LEAD ALLOGENEIC CELL THERAPY CELZ-201 Source text: ID:nGNX4P52Zt Further company coverage: CELZ.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Buys 4 Million Biodefense Shares For $200,000 Cash And 1 Million Shares On Sept 24
Brief: Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM